
Education and Training
- Fellowship, Medical Oncology, Yale University, 2006 - 2009
- Residency, Internal Medicine, Penn State Milton S. Hershey Medical Center, 2002 - 2005
- D.O., New York Institute of Technology, College of Osteopathic Medicine, 2001
Grants
- Aravive 003: AVB-S6-500 A phase 1b/2 study of AVB-S6-500 in combination with cabozantinib, AVB-S6-500 in combination with cabozantinib and nivolumab, and AVB-S6-500 monotherapy in patients with advanced of metastatic clear cell renal cell carcinoma
- Keynote B15 - EV/Pembro vs GEM/CIS in muscle-invasive bladder cancer
- An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab with or without chemotherapy, versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer
- NeoImmune NMTNT110
- A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (Mirati 516-003)